Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
US Market
Holding YMAB?
Track your performance easily

Y-Mabs Therapeutics (YMAB) Financial Statements

211 Followers

Y-Mabs Therapeutics Financial Overview

Y-Mabs Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.496; its P/E ratio is -25.14; Y-Mabs Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 23.36M$ 20.45M$ 20.75M$ 20.25M-
Gross Profit$ 21.32M$ 17.86M$ 16.10M$ 18.17M-
EBIT$ -3.20M$ -7.56M$ -6.12M$ -6.39M-
EBITDA$ -3.04M-$ -5.90M$ -6.21M-
Net Income Common Stockholders$ -988.00K$ -7.84M$ -6.30M$ -6.39M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 78.64M$ 86.57M$ 87.91M$ 92.63M$ 105.76M
Total Assets$ 127.87M$ 128.88M$ 132.40M$ 136.93M$ 141.46M
Total Debt$ 1.42M$ 1.62M$ 1.25M$ 1.48M$ 1.77M
Net Debt$ -77.22M$ -84.95M$ -86.66M$ -91.14M$ -104.00M
Total Liabilities$ 26.88M$ 28.73M$ 27.71M$ 29.62M$ 32.23M
Stockholders Equity$ 100.98M$ 100.15M$ 104.68M$ 107.83M$ 109.22M
Cash Flow-
Free Cash Flow$ -8.04M-$ -4.73M$ -13.12M-
Operating Cash Flow$ -8.04M$ -1.34M$ -4.73M$ -13.12M-
Investing Cash Flow-----
Financing Cash Flow$ 100.00K----
Currency in USD

Y-Mabs Therapeutics Earnings and Revenue History

Y-Mabs Therapeutics Debt to Assets

Y-Mabs Therapeutics Cash Flow

Y-Mabs Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis